SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Clown-Free Zone... sorry, no clowns allowed -- Ignore unavailable to you. Want to Upgrade?


To: Les H who wrote (34123)11/6/2000 12:52:55 PM
From: Archie Meeties  Read Replies (1) | Respond to of 436258
 
Wouldn't downplay Viox's potential market. The cox-2 inhibitors may be the therapy of choice for all people on long term NSAID use. A huge market.



To: Les H who wrote (34123)11/6/2000 1:00:06 PM
From: LLCF  Read Replies (1) | Respond to of 436258
 
<Since when does a stock go up because its test drug is better than a placebo...>

You're kidding right?? Tons of studies are vs placebo.

DAK